fingolimod hydrochloride has been researched along with Retinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, S; Aziz, A; Egom, EE; Elfaki, MY; Memon, D; Shiwani, HA | 1 |
| Fusi-Rubiano, W; Gupta, A; Keane, PA; Mandal, P; Yang, Y | 1 |
2 review(s) available for fingolimod hydrochloride and Retinal Diseases
| Article | Year |
|---|---|
Updates on sphingolipids: Spotlight on retinopathy.
Topics: Animals; Ceramides; Fingolimod Hydrochloride; Humans; Lysophospholipids; Molecular Targeted Therapy; Photoreceptor Cells, Vertebrate; Retina; Retinal Diseases; Retinal Ganglion Cells; Retinal Pigment Epithelium; Signal Transduction; Sphingolipids; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors | 2021 |
Fingolimod: therapeutic mechanisms and ocular adverse effects.
Topics: Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Retina; Retinal Diseases; Risk Assessment; Visual Acuity | 2017 |